Shantha Biologics, a Hyderabad-based pharmaceutical manufacturing company, has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India. The collaboration underscores Shantha Biologics’ commitment to high-quality manufacturing execution and its reputation as a trusted partner to global healthcare companies.
Collaboration Details
The agreement will be governed by a contractual framework agreed upon by both parties and will be carried out in accordance with applicable quality, compliance, and regulatory requirements. No financial terms or further details of the agreement are being disclosed.
Leadership Comments
“We are pleased to enter into this collaboration, which reflects the confidence placed in Shantha Biologics’ capabilities and our commitment to reliable, high-quality cartridge fill-finish services,” said Dr. Vishy Chebrol, Director of Shantha Biologics. “We look forward to supporting this partnership through strong operational execution and a continued focus on quality and compliance.”
About Shantha Biologics
Shantha Biologics is a pharmaceutical manufacturing company based in Hyderabad, India, with capabilities spanning vaccines, biologics, and specialized sterile manufacturing. The company operates purpose-built sterile fill-finish capacity, including cartridge filling, and partners with global pharmaceutical and biotechnology companies to deliver high-quality development and aseptic manufacturing that meets international quality and compliance standards.
